Verapamil for newly diagnosed type 1 diabetes in youth
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether an oral blood pressure medicine called verapamil can help preserve insulin-making cells in children and teens recently diagnosed with type 1 diabetes. It may slow the disease and reduce how much insulin you need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 18 years old
- You were diagnosed with type 1 diabetes within the last 6 weeks
- You have at least two positive diabetes-related antibodies in your blood
- You are willing to take an oral medication and follow study procedures
- You do not have other autoimmune or endocrine conditions, heart issues, or severe liver/kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether teplizumab can help keep the body making insulin in people recently diagnosed with type 1 diabetes. It is for children and young adults aged 1 to 25, and compares the drug against a placebo.
This study tests a new gene therapy (VV-14300) that aims to help people with type 1 diabetes make insulin again. It might improve blood sugar control and reduce the need for insulin.
This trial tests a new medicine (rezpegaldesleukin) to see if it can help preserve the body's ability to make some insulin in people recently diagnosed with type 1 diabetes. It's for children and adults diagnosed within the past 100 days.
This trial tests an investigational gene therapy that may help people with type 1 diabetes produce some insulin on their own, potentially reducing the amount of insulin they need. It is an early-stage study, so participants will be closely monitored for safety and any changes in their diabetes control.
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
This study observes how well the Control-IQ insulin pump system works for teenagers with type 1 diabetes who exercise at least twice a week. It aims to see if the technology is safe and effective during regular physical activity.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.